Advertisement
Cancer survivors with high-deductible health plans are more likely to experience delayed or foregone care

Delayed/Foregone Care More Likely for Cancer Survivors With HDHPs

0
Having a health savings account can mitigate the impact of the high-deductible health plan
In a two-part guideline

Guidelines Issued for Managing Hidradenitis Suppurativa

0
Two-part guideline addresses diagnosis, evaluation, management of the chronic inflammatory skin disease
Osteoarthritis is an independent risk factor for increased cardiovascular disease

NSAIDs Contribute to Increased CVD Risk in Osteoarthritis

0
Considerable proportion of increased CHF, IHD, and stroke risk mediated by NSAID use
Warning letters about 44 flavored e-liquid and hookah tobacco products being sold illegally in the United States have been sent to four companies

Warnings Issued to Companies Illegally Selling E-Liquid, Hookah Products

0
FDA says companies are selling products without required marketing authorization
For women with intrahepatic cholestasis of pregnancy

Common Therapy for Obstetric Cholestasis Found Ineffective

0
Treatment with ursodeoxycholic acid versus placebo yielded no significant difference in outcome
Sotagliflozin

Addition of Sotagliflozin for T1DM Alters Renal Hemodynamics

0
Addition of SOTA tied to reductions in estimated glomerular filtration rate, blood pressure
The maker of Zolgensma (onasemnogene abeparvovec-xioi) gave manipulated data to the U.S. Food and Drug Administration when it approved the drug

FDA: Approval of Zolgensma Was Based on Manipulated Data

0
Despite inaccurate data, FDA says it is 'confident that Zolgensma should remain on the market'
Antidepressants strongly inhibiting serotonin reuptake may be associated with a small reduction in the rate of ischemic stroke compared with weak reuptake inhibitors

Strong SSRI May Be Tied to Small Decrease in Ischemic Stroke Risk

0
Rate of myocardial infarction similar with current use of strong, weak selective serotonin reuptake inhibitors
Spending associated with essential medicines grew substantially from 2011 to 2015 for Medicare Part D beneficiaries

Medicare Spending on Essential Medicines Up 116 Percent From 2011 to 2015

0
22 percent of increased total spending due to higher per-unit cost of existing drugs
Preterm infants

Completion Rates of Recommended Vaccines Lower for Preemies

0
Rate of completion lower for seven-vaccine series by 19 months and 36 months of age